Brought to you by 
Semprus BioSciences brings in $18mm through its Series B round
27 Dec 2010
Executive Summary
Semprus BioSciences Corp. has raised $18mm through the closing of its Series B venture round. SR One and Foundation Medical Partners co-led the financing (and will each contribute one board member) and were joined by existing investors 5AM Ventures and Pangaea Ventures. The company is developing the Semprus Sustain, which interrupts the way bacteria and blood interact with medical devices to prevent or at least limit complications due to infection and thrombus formation.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Infection Control-Sterilization
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Semprus BioSciences brings in $18mm through its Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice